For Physicians
Company
Support
Sign in
Register
Home
Question
Would you use neoadjuvant CDK4/6 inhibitor and AI in HR+ breast cancer based upon the randomized phase II CORALLEEN trial?
1 Answers
Add Answer
Mednet Member
Medical Oncology · Cedars-Sinai Medical Center
I would not use CDK inhibitors in the neoadjuvant setting.
Register
or
Sign In
to see full answer
Would you use neoadjuvant CDK4/6 inhibitor and AI in HR+ breast cancer based upon the randomized phase II CORALLEEN trial? | Mednet
